Recombinant Human SLC1A1 Protein，His

SLC1A1, a member of the solute carrier family, encodes a high-affinity neurotransmitter transporter primarily responsible for the uptake of glutamate in the central nervous system. Dysregulation of glutamate homeostasis is linked to various neurological disorders, including epilepsy, schizophrenia, and neurodegenerative diseases. As the primary excitatory neurotransmitter, glutamate plays a crucial role in synaptic transmission, plasticity, and overall brain function. Given the importance of SLC1A1 in maintaining glutamatergic signaling, researchers have focused on characterizing its structure and function through the study of recombinant SLC1A1 proteins. These recombinant proteins offer a valuable tool for elucidating the transporter’s mechanism of action, its interaction with various substrates and inhibitors, and its role in synaptic dynamics. Additionally, understanding the molecular basis of SLC1A1 function can provide insights into how alterations in its activity contribute to neuronal excitability and pathophysiology of mental disorders. Furthermore, the development of targeted pharmacological agents that modulate SLC1A1 activity has the potential to pave the way for novel therapeutic strategies to treat glutamate-related conditions. Overall, the study of recombinant SLC1A1 proteins represents a critical avenue in neurobiology, enabling researchers to dissect the complexities of glutamate transport and its implications for brain health and disease.